Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopenia.

@article{Alves2004ThromboticRI,
  title={Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopenia.},
  author={Jos{\'e} Delgado Alves and Murat Inanç and Reyhan Diz-Kucukkaya and Bruno Grima and Francisco Soromenho and David Isenberg},
  journal={European journal of internal medicine},
  year={2004},
  volume={15 3},
  pages={
          162-167
        }
}
Background: Splenectomy has been performed to treat refractory autoimmune thrombocytopenia. However, some reports have suggested that an increased risk of thrombosis could be present in splenectomized patients. This study aims to evaluate the possibility of an increased risk of thrombosis after splenectomy in patients with systemic lupus and antiphospholipid syndrome. Methods: Thrombotic-related events in patients with systemic lupus erythematosus (SLE) and/or primary antiphospholipid syndrome… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis

Nahim Barron, Jesús Arenas-Osuna, +5 authors Luis J. Jara
  • Clinical Rheumatology
  • 2018
VIEW 2 EXCERPTS
CITES BACKGROUND